Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3896478rdf:typepubmed:Citationlld:pubmed
pubmed-article:3896478lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:3896478lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3896478lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:3896478lifeskim:mentionsumls-concept:C0205332lld:lifeskim
pubmed-article:3896478pubmed:issue9lld:pubmed
pubmed-article:3896478pubmed:dateCreated1985-9-30lld:pubmed
pubmed-article:3896478pubmed:abstractTextMonoclonal antibody AB/3 was produced from a fusion of spleen cells of a human breast cancer cell-primed BALB/c mouse with the murine myeloma cell line P3-NS1-Ag4-1. The antibody reacted strongly with the plasma membrane of human breast cancer cells. Tissue sections of both malignant and benign human mammary carcinomas and tumors of non-breast origin as well as apparently normal tissues were tested with immunoperoxidase. Ninety-six of 124 (77%) primary human breast cancers, 12 of 14 (86%) metastatic breast lesions, and 12 of 44 (27%) benign breast lesions reacted positively. Little or no appreciable reactivity was observed with apparently normal human tissues and carcinomas of non-breast origin, with the exception of colon carcinoma. Antibody AB/3 did not immunoprecipitate any identifiable protein from radiolabeled extracts of the immunizing cell line.lld:pubmed
pubmed-article:3896478pubmed:languageenglld:pubmed
pubmed-article:3896478pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3896478pubmed:citationSubsetIMlld:pubmed
pubmed-article:3896478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3896478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3896478pubmed:statusMEDLINElld:pubmed
pubmed-article:3896478pubmed:monthSeplld:pubmed
pubmed-article:3896478pubmed:issn0008-5472lld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:NegriniRRlld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:IacobelliSSlld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:NatoliCClld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:SanteusanioGGlld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:ScambiaGGlld:pubmed
pubmed-article:3896478pubmed:authorpubmed-author:NatoliVVlld:pubmed
pubmed-article:3896478pubmed:issnTypePrintlld:pubmed
pubmed-article:3896478pubmed:volume45lld:pubmed
pubmed-article:3896478pubmed:ownerNLMlld:pubmed
pubmed-article:3896478pubmed:authorsCompleteYlld:pubmed
pubmed-article:3896478pubmed:pagination4334-8lld:pubmed
pubmed-article:3896478pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:meshHeadingpubmed-meshheading:3896478-...lld:pubmed
pubmed-article:3896478pubmed:year1985lld:pubmed
pubmed-article:3896478pubmed:articleTitleA monoclonal antibody (AB/3) reactive with human breast cancer.lld:pubmed
pubmed-article:3896478pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3896478pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed